APPLICATION
ANDA090291
TYPE
ANDA
ORIGINAL APPROVAL
2010-12-21
LATEST ACTION
2017-08-15
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CEFEPIME HYDROCHLORIDEDiscontinued
CEFEPIME HYDROCHLORIDE EQ 2GM BASE/VIAL · INJECTABLE · INJECTION
CEFEPIME HYDROCHLORIDEDiscontinued
CEFEPIME HYDROCHLORIDE EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
CEFEPIME HYDROCHLORIDEDiscontinued
CEFEPIME HYDROCHLORIDE EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
Approval history
2017-08-15Labeling · Supplement 2 · standardAP
2010-12-21OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.